Betahistine Mesilate
甲磺酸倍他司汀
Report date: 2023/01/13 20:00:32
Base Information
Drug NameBetahistine Mesilate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A